Time-Driven, Activity-Based Cost Analysis of Secondary Intraocular Lens Implantation
Ryan S Meshkin1, Samantha E Hoffman1,2, Celine Chaaya Md1
1Department of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA, USA.
Journal of Vitreoretinal Diseases
|April 10, 2026
Summary
Secondary intraocular lens procedures with pars plana vitrectomy (PPV) are largely unprofitable under current Medicare reimbursement rates. Most cases incur a net loss, indicating a need for increased reimbursement to ensure economic sustainability.
Area of Science:
- Ophthalmology
- Health Economics
Background:
- Secondary intraocular lens (IOL) procedures are often necessary to correct visual deficits after initial cataract surgery.
- These procedures, when combined with pars plana vitrectomy (PPV), represent complex ophthalmic surgeries.
- Assessing the economic viability of these procedures is crucial for healthcare providers and institutions.
Purpose of the Study:
- To determine the break-even times for secondary IOL procedures (repositioning, insertion, exchange) when performed with PPV.
- To evaluate the profitability of these procedures under current Medicare reimbursement rates for hospitals.
- To identify the economic sustainability of complex secondary IOL surgeries.
Main Methods:
- Retrospective review of 97 secondary IOL procedures with PPV performed in 2023.
- Analysis of Current Procedural Terminology (CPT) billing codes for specific secondary IOL procedures (66825, 66985, 66986).
- Calculation of total operative costs and Medicare reimbursement rates to determine break-even times and net margins.
Main Results:
- The majority of secondary IOL procedures (85.56%) with PPV were unprofitable, with median net losses ranging from -$822.40 to -$3395.04.
- Break-even times for single-surgeon procedures ranged from 75.96 to 77.05 minutes.
- Operative times frequently exceeded break-even times, with a median difference of 13.96 to 46.91 minutes.
Conclusions:
- Current Medicare reimbursement rates are insufficient to cover the costs of secondary IOL procedures performed with PPV.
- Increased reimbursement is necessary for the economic sustainability of these complex ophthalmic procedures.
- Maintaining high standards of care necessitates addressing the financial challenges associated with these surgeries.

